Tangential flow filtration based protein refolding methods

US10183967B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10183967-B2
Application numberUS-201414766849-A
CountryUS
Kind codeB2
Filing dateFeb 11, 2014
Priority dateFeb 12, 2013
Publication dateJan 22, 2019
Grant dateJan 22, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are methods for refolding proteins that are denatured. Exemplary methods comprise solubilizing the denatured protein with a denaturing agent, e.g., a chaotropic agent, and renaturing the protein using a buffer exchanging system, e.g., tangential flow filtration (TFF).

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for refolding a denatured protein, e.g., that is present in inclusion bodies (IBs), comprising (i) providing the denatured protein that is present in IBs, wherein the protein comprises a tenth fibronectin type III ( 10 Fn3) domain and an Fc region; (ii) suspending denatured protein in a suspension solution, to obtain a composition comprising suspended denatured protein; (iii) combining the composition comprising suspended denatured protein with a solubilization buffer that comprises a denaturing agent and has a pH in the range of 7 to 10, wherein the denaturing agent is guanidine or guanidinium, to obtain a first protein composition comprising solubilized denatured protein; (iv) diafiltering the first protein composition comprising solubilized denatured protein with 2-4 diavolumes of a refold buffer that comprises arginine and has a pH in the range of 9 to 11 to obtain a second protein composition comprising partially refolded protein; and (v) incubating the second protein composition comprising partially refolded protein with a refold/oxidizing buffer that comprises arginine and glutathione and has a pH in the range of 9 to 11 to obtain a third protein composition comprising the protein in a refolded state. 2. The method of claim 1 , wherein step (v) comprises diafiltering the second protein composition with 2-6 diavolumes of a refold/oxidizing buffer. 3. The method of claim 1 , wherein diafiltering with refold buffer takes between 0.5 to 3 hours. 4. The method of claim 2 , wherein the diafiltering with the refold/oxidizing buffer takes between 0.5 to 3 hours. 5. The method of claim 1 , wherein the denatured protein is suspended in a suspension solution at a ratio of weight (grams) of denatured protein:volume (ml) of suspension solution of 1:1-10. 6. The method of claim 1 , wherein the composition comprising solubilized denatured protein is not diluted prior to diafiltering. 7. The method of claim 1 , wherein the composition comprising solubilized denatured protein is filtered prior to diafiltering. 8. The method of claim 1 , wherein the third protein composition comprises 1-10 mg/ml of protein. 9. The method of claim 1 , wherein the protein in refolded state has an efficiency of recovery is at least about 70%. 10. The method of claim 1 , wherein the denatured protein comprises at least one disulfide bond. 11. The method of claim 1 , wherein the solubilization buffer, refold buffer, and/or refold/oxidizing buffer comprises Tris.

Assignees

Inventors

Classifications

  • Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto · CPC title

  • by filtration, ultrafiltration or reverse osmosis · CPC title

  • C07K1/1136Primary

    by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents · CPC title

  • Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG] · CPC title

  • Constant or Fc region; Isotype · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10183967B2 cover?
Provided herein are methods for refolding proteins that are denatured. Exemplary methods comprise solubilizing the denatured protein with a denaturing agent, e.g., a chaotropic agent, and renaturing the protein using a buffer exchanging system, e.g., tangential flow filtration (TFF).
Who is the assignee on this patent?
Bristol Myers Squibb Co
What technology area does this patent fall under?
Primary CPC classification C07K1/1136. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).